Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Every year, millions of people face the ordeal of painful implant complications—22 percent develop peri-implantitis, and 43 percent show symptoms of peri-implant mucositis, according to a large-scale study review by Derks and Tomasi. Behind those statistics are real lives disrupted by discomfort, costly treatments, and the emotional toll of failed restorations. For too long, the profession treated these outcomes as inevitable. But in Zurich, one company refused to accept that status quo—and set out to change the story. Founded in 2019, Patent™ introduced a breakthrough system that eliminates peri-implantitis—not by treating it after the fact, but by preventing it entirely. Drawing from long-term scientific studies and real-world clinical experience, Patent™ has established itself as a system designed to preserve soft-tissue health, maintain esthetic outcomes, and ensure biological success where other implants fall short. Reframing the Peri-implantitis Problem Peri-implantitis, once viewed as a complication caused by poor dental hygiene or patient non-compliance, has now been recognized as a structural flaw in traditional implant design. Most dental implants rely solely on osseointegration—a mechanical bond with bone—while ignoring the soft tissue interface. This oversight creates a biological gap vulnerable to plaque infiltration. Plaque and bacteria can migrate downward along the implant surface, penetrate the surrounding mucosa, and eventually
For small and micro-businesses, regulatory compliance isn’t just a requirement—it’s a gateway to market credibility. Yet, without the right support, this can be an intimidatingly complex pathway. Advena’s deep regulatory expertise opens doors, transforming compliance into a strategic asset that accelerates clients’ journeys to market. “Our goal is to empower clients by simplifying the regulatory process, driving innovation rather than becoming an obstacle,” explains Kirsty Ostle, Managing Director. Advena’s robust suite of services includes navigating complex UK and EU regulatory and quality frameworks, to fulfilling essential roles such as the UK Responsible Person, a role required by the UK Medical Device Regulations for non-UK manufacturers and Person Responsible for Regulatory Compliance (PRRC) required by the EU Medical Device and IVD Regulations. This way, Advena becomes a committed partner at every stage of the compliance journey. Not only does it ensure compliance, but it also strengthens clients’ operations from the ground up. Through audits aligned with ISO 13485 and ISO 9001, Advena introduces best practices that enhance operational resilience. Its seasoned auditors conduct thorough reviews, assessing both in-house and supplier processes, evaluating quality management systems and delivering actionable recommendations to elevate client efficiency and reliability. Education is woven into everything Advena does. Beyond traditional consulting, it empowers clients through tailored training, auditing and supplier assessments that build both confidence and knowledge. Bespoke training sessions—available virtually or onsite—equip teams with practical skills, ensuring they are well-prepared to meet regulatory demands independently and sustainably. For businesses looking to establish themselves in complex markets, Advena is a versatile resource, turning compliance into a true competitive edge.
Advancements in ophthalmic diagnostics technologies are opening new possibilities for smarter workflows and consistent, high-quality imaging. Topcon Healthcare is spearheading this movement with the highest quality solutions designed with Japanese innovation. A global provider of optical coherence tomography (OCT) and fundus imaging technology, the company is leading the industry with its flagship devices, including the Maestro2, DRI OCT Triton and NW500. Its products empower clinicians to detect, assess and manage eye diseases with high-quality data, quickly. By integrating automated intelligence with clinical reliability, Topcon Healthcare enhances the efficacy and accessibility of eye care. Each system reflects its commitment to simplifying the demands of modern eye care, from automated multimodal imaging and data consolidation to workflow integration and clinical decision-making. For instance, many clinics face mounting pressure to deliver consistent, high-quality diagnostic results while handling patient load, fragmented systems and rising administrative demands. At the same time, there is an increasing need to ensure data security, meet interoperability standards and uphold clinical accuracy without sacrificing time. Topcon Healthcare addresses these challenges by developing systems and software that function as part of an interconnected, intelligent workflow rather than isolated devices that require constant workarounds. This approach is reflected in Maestro2, a multimodal imaging system that captures fundus photography simultaneously with OCT or OCT angiography within a single, automated scan. It streamlines image acquisition and removes the need for multiple instruments or manual inputs. With this system, eye care professionals can access a detailed assessment of ocular health in less time, and staff can confidently delegate imaging responsibilities, given the system’s built-in repeatability and precision.
Spine Solutions
Vratislava Kovarova, Senior director patients’ safety and sustainability, Fresenius Medical Care – Europe Middle East & Africa
Medical Device Consulting
An interview with Stefanie Hirsch, President for Quality and Regulatory Affairs at Drägerwerk AG & Co. KGaA (Dräger)
Cardiovascular Devices
Greg Mtunz, General Manager Diagnostic Services, Buckinghamshire Healthcare NHS Trust
Orthopedic
Gisella Murguia Norlander, General Dentist, Folktandvården Stockholm AB
Ablation Devices
Dr Katrien De Ketelaere, MD, Medical Director AZ Sint Lucas Ghent-Belgium
Medical Device Consulting
Alphons Vincent, Medical Director at Medtronic
Cardiovascular Devices
Sophia Neisinger, Dermatology/Allergology, Charite
Non-invasive heart risk tools are transforming cardiovascular care in Europe through better access, clinical precision, and seamless healthcare integration.
Technological advancements in dental implants in Europe improve precision, durability, and patient outcomes through digital dentistry, advanced biomaterials, and innovative surgical techniques, ensuring safer, faster, and more effective.
Advancing Patient Care Across Specialities
Dental implants now combine advanced biomaterials and digital workflows to restore oral health. Non-invasive cardiovascular risk assessment devices enable earlier detection and monitoring of heart health, reducing the likelihood of complications that might affect multiple organs, including the brain. Neurosurgery products, supported by next- generation guidance systems, ensure that when intervention is required, procedures are performed with unprecedented accuracy and reduced patient risk.
Taken together, these technologies represent a continuum of care that spans prevention and monitoring, restoration and high-stakes intervention. They highlight how European innovation is advancing in an interconnected way, weaving a fabric of solutions that collectively raise the standard of patient care across specialities.
This edition of MedTech Outlook Europe explores these crossdisciplinary breakthroughs, spotlighting leaders and innovators who are shaping the future of healthcare.
Featured thought leaders include Stefanie Hirsch, Chief Sustainability & Quality Officer - Member of the Executive Board at Drägerwerk AG & Co. KGaA (Dräger). She highlights how the healthcare industry is evolving through sustainability, regulatory compliance and emerging technologies like telemedicine, AI, wearables and xenotransplantation to improve patient care and long-term resilience.
Sophia Neisinger, Medical Doctor, Dermatology & Allergology Resident | Researcher at Charit, emphasises the importance of adapting to rapid advancements in oncology through patient-centred care, innovation, collaboration and leadership to continuously improve treatment and outcomes.
We hope this edition gives you fresh perspectives and practical insights that help you strengthen collaboration and play a part in advancing patient care across Europe and beyond.
